Active	Status	Sponsor type	Region	Phase	Filter
15 Active 28 Inactive 43 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

15 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Sofuoglu, Mehmet
NCT04535362: Nicotine's Potential Abuse With Menthol	Completed	1	16	US	Nicotine, intravenous nicotine	Yale University, National Institute on Drug Abuse (NIDA)	Nicotine Dependence	06/23	06/23
NCT05159934: Nicotine Differences in Smokers	Completed	1	11	US	0.05, 0.025, and 0.0125 mg nicotine/pulse of nicotine, Saline	Yale University	Nicotine Dependence	07/23	08/23
NCT05176418: IV Pulsed-Nicotine As a Model of Smoking: the Effects of Dose and Delivery Rate	Recruiting	1	70	US	low dose Nicotine, IV nicotine 1mg/70kg, high dose Nicotine, IV Nicotine 0.2/70kg	Yale University	Nicotine Dependence	08/25	09/25
NCT06096714: Addictive Threshold of Nicotine	Recruiting	1	36	US	Nicotine, Saline	Yale University, National Institute on Drug Abuse (NIDA)	Smoking Addiction	01/27	01/27
Aquino, Joao De
NCT06544291: Combined THC and CBD for OUD and Chronic Pain	Recruiting	2	147	US	CBD 300mg, Nantheia™ ATL5 (300mg), CBD 600mg, Nantheia™ ATL5 (600mg), Placebo 0mg, Nantheia™ ATL5 (0mg)	Yale University, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH)	Chronic Pain, Opioid Use Disorder	01/28	01/28
NCT05076370: Safety and Tolerability of Cannabidiol Among Persons With Opioid Use Disorder Receiving Methadone or Buprenorphine	Completed	1	7	US	CBD Day 1, CBD Day 2, CBD Day 3	Yale University, National Institute on Drug Abuse (NIDA)	Addiction	06/24	06/24
NCT04587791: Cannabidiol in Opioid Use Disorder and Chronic Pain	Recruiting	1	40	US	400mg Cannabidiol, CBD, 800mg Cannabidiol, 1200mg Cannabidiol, Saline, placebo	Yale University, VA Connecticut Healthcare System, National Institute on Drug Abuse (NIDA)	Chronic Pain	02/25	03/25
NCT04025359: Effects of Dronabinol in Opioid Maintained Patients	Recruiting	1	36	US	Dronabinol, Marinol, Placebo	Yale University, US Department of Veterans Affairs	Pain	02/25	06/25
NCT05906511: PK/PD of Oral and Vaporized Delta-9-Tetrahydrocannabinol (THC) in Older Adults	Recruiting	1	20	US	Dronabinol 5 MG, "Marinol", Dronabinol 10 MG, 2mg Purified THC in an ethanolic solution, 4mg Purified THC in an ethanolic solution, Placebo	Yale University, VA Connecticut Healthcare System, National Institute on Drug Abuse (NIDA)	Pain, Tolerance, Oral vs Vaporized THC, Abuse Liability	08/25	08/25
Sullivan, Brendan
NCT05159934: Nicotine Differences in Smokers	Completed	1	11	US	0.05, 0.025, and 0.0125 mg nicotine/pulse of nicotine, Saline	Yale University	Nicotine Dependence	07/23	08/23
NCT05076370: Safety and Tolerability of Cannabidiol Among Persons With Opioid Use Disorder Receiving Methadone or Buprenorphine	Completed	1	7	US	CBD Day 1, CBD Day 2, CBD Day 3	Yale University, National Institute on Drug Abuse (NIDA)	Addiction	06/24	06/24
NCT04025359: Effects of Dronabinol in Opioid Maintained Patients	Recruiting	1	36	US	Dronabinol, Marinol, Placebo	Yale University, US Department of Veterans Affairs	Pain	02/25	06/25
NCT05906511: PK/PD of Oral and Vaporized Delta-9-Tetrahydrocannabinol (THC) in Older Adults	Recruiting	1	20	US	Dronabinol 5 MG, "Marinol", Dronabinol 10 MG, 2mg Purified THC in an ethanolic solution, 4mg Purified THC in an ethanolic solution, Placebo	Yale University, VA Connecticut Healthcare System, National Institute on Drug Abuse (NIDA)	Pain, Tolerance, Oral vs Vaporized THC, Abuse Liability	08/25	08/25
NCT06096714: Addictive Threshold of Nicotine	Recruiting	1	36	US	Nicotine, Saline	Yale University, National Institute on Drug Abuse (NIDA)	Smoking Addiction	01/27	01/27
MacLean, Robert R
ACT-SS, NCT04567680: Acceptance and Commitment Therapy to Improve Social Support for Veterans With PTSD	Active, not recruiting	N/A	120	US	Acceptance and Commitment Therapy to Improve Social Support for Veterans with PTSD, ACT-SS, Present-Centered Therapy, PCT	VA Office of Research and Development	Post-traumatic Stress Disorder	04/24	03/25